Skip to main content
NCBI home page
Journal of Virology logoLink to Journal of Virology
. 1995 Jun;69(6):3324–3332. doi: 10.1128/jvi.69.6.3324-3332.1995

Function of a unique sequence motif in the long terminal repeat of feline leukemia virus isolated from an unusual set of naturally occurring tumors.

G B Athas 1, P Lobelle-Rich 1, L S Levy 1
PMCID: PMC189044  PMID: 7745680

Abstract

Feline leukemia virus (FeLV) proviruses have been characterized from naturally occurring non-B-cell, non-T-cell tumors occurring in the spleens of infected cats. These proviruses exhibit a unique sequence motif in the long terminal repeat (LTR), namely, a 21-bp tandem triplication beginning 25 bp downstream of the enhancer. The repeated finding of the triplication-containing LTR in non-B-cell, non-T-cell lymphomas of the spleen suggests that the unique LTR is an essential participant in the development of tumors of this particular phenotype. The nucleotide sequence of the triplication-containing LTR most closely resembles that of FeLV subgroup C. Studies performed to measure the ability of the triplication-containing LTR to modulate gene expression indicate that the 21-bp triplication provides transcriptional enhancer function to the LTR that contains it and that it substitutes at least in part for the duplication of the enhancer. The 21-bp triplication confers a bona fide enhancer function upon LTR-directed reporter gene expression; however, the possibility of a spacer function was not eliminated. The studies demonstrate further that the triplication-containing LTR acts preferentially in a cell-type-specific manner, i.e., it is 12-fold more active in K-562 cells than is an LTR lacking the triplication. A recombinant, infectious FeLV bearing the 21-bp triplication in U3 was constructed. Cells infected with the recombinant were shown to accumulate higher levels of viral RNA transcripts and virus particles in culture supernatants than did cells infected with the parental type. The triplication-containing LTR is implicated in the induction of tumors of a particular phenotype, perhaps through transcriptional regulation of the virus and/or adjacent cellular genes, in the appropriate target cell.

Full Text

The Full Text of this article is available as a PDF (408.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Athas G. B., Starkey C. R., Levy L. S. Retroviral determinants of leukemogenesis. Crit Rev Oncog. 1994;5(2-3):169–199. doi: 10.1615/critrevoncog.v5.i2-3.40. [DOI] [PubMed] [Google Scholar]
  2. Berg P. E., Popovic Z., Anderson W. F. Promoter dependence of enhancer activity. Mol Cell Biol. 1984 Aug;4(8):1664–1668. doi: 10.1128/mcb.4.8.1664. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bonham L., Lobelle-Rich P. A., Henderson L. A., Levy L. S. Transforming potential of a myc-containing variant of feline leukemia virus in vitro in early-passage feline cells. J Virol. 1987 Oct;61(10):3072–3081. doi: 10.1128/jvi.61.10.3072-3081.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Boral A. L., Okenquist S. A., Lenz J. Identification of the SL3-3 virus enhancer core as a T-lymphoma cell-specific element. J Virol. 1989 Jan;63(1):76–84. doi: 10.1128/jvi.63.1.76-84.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bösze Z., Thiesen H. J., Charnay P. A transcriptional enhancer with specificity for erythroid cells is located in the long terminal repeat of the Friend murine leukemia virus. EMBO J. 1986 Jul;5(7):1615–1623. doi: 10.1002/j.1460-2075.1986.tb04404.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Casey J. W., Roach A., Mullins J. I., Burck K. B., Nicolson M. O., Gardner M. B., Davidson N. The U3 portion of feline leukemia virus DNA identifies horizontally acquired proviruses in leukemic cats. Proc Natl Acad Sci U S A. 1981 Dec;78(12):7778–7782. doi: 10.1073/pnas.78.12.7778. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chen H., Yoshimura F. K. Identification of a region of a murine leukemia virus long terminal repeat with novel transcriptional regulatory activities. J Virol. 1994 May;68(5):3308–3316. doi: 10.1128/jvi.68.5.3308-3316.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Chirgwin J. M., Przybyla A. E., MacDonald R. J., Rutter W. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 1979 Nov 27;18(24):5294–5299. doi: 10.1021/bi00591a005. [DOI] [PubMed] [Google Scholar]
  9. Cleveland D. W., Lopata M. A., MacDonald R. J., Cowan N. J., Rutter W. J., Kirschner M. W. Number and evolutionary conservation of alpha- and beta-tubulin and cytoplasmic beta- and gamma-actin genes using specific cloned cDNA probes. Cell. 1980 May;20(1):95–105. doi: 10.1016/0092-8674(80)90238-x. [DOI] [PubMed] [Google Scholar]
  10. DesGroseillers L., Jolicoeur P. The tandem direct repeats within the long terminal repeat of murine leukemia viruses are the primary determinant of their leukemogenic potential. J Virol. 1984 Dec;52(3):945–952. doi: 10.1128/jvi.52.3.945-952.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Donahue P. R., Hoover E. A., Beltz G. A., Riedel N., Hirsch V. M., Overbaugh J., Mullins J. I. Strong sequence conservation among horizontally transmissible, minimally pathogenic feline leukemia viruses. J Virol. 1988 Mar;62(3):722–731. doi: 10.1128/jvi.62.3.722-731.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Fulton R., Plumb M., Shield L., Neil J. C. Structural diversity and nuclear protein binding sites in the long terminal repeats of feline leukemia virus. J Virol. 1990 Apr;64(4):1675–1682. doi: 10.1128/jvi.64.4.1675-1682.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Golemis E. A., Speck N. A., Hopkins N. Alignment of U3 region sequences of mammalian type C viruses: identification of highly conserved motifs and implications for enhancer design. J Virol. 1990 Feb;64(2):534–542. doi: 10.1128/jvi.64.2.534-542.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hanecak R., Pattengale P. K., Fan H. Deletion of a GC-rich region flanking the enhancer element within the long terminal repeat sequences alters the disease specificity of Moloney murine leukemia virus. J Virol. 1991 Oct;65(10):5357–5363. doi: 10.1128/jvi.65.10.5357-5363.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Holland C. A., Thomas C. Y., Chattopadhyay S. K., Koehne C., O'Donnell P. V. Influence of enhancer sequences on thymotropism and leukemogenicity of mink cell focus-forming viruses. J Virol. 1989 Mar;63(3):1284–1292. doi: 10.1128/jvi.63.3.1284-1292.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hoover E. A., Mullins J. I. Feline leukemia virus infection and diseases. J Am Vet Med Assoc. 1991 Nov 15;199(10):1287–1297. [PubMed] [Google Scholar]
  17. Levesque K. S., Bonham L., Levy L. S. flvi-1, a common integration domain of feline leukemia virus in naturally occurring lymphomas of a particular type. J Virol. 1990 Jul;64(7):3455–3462. doi: 10.1128/jvi.64.7.3455-3462.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Levy L. S., Gardner M. B., Casey J. W. Isolation of a feline leukaemia provirus containing the oncogene myc from a feline lymphosarcoma. 1984 Apr 26-May 2Nature. 308(5962):853–856. doi: 10.1038/308853a0. [DOI] [PubMed] [Google Scholar]
  19. Li Y., Golemis E., Hartley J. W., Hopkins N. Disease specificity of nondefective Friend and Moloney murine leukemia viruses is controlled by a small number of nucleotides. J Virol. 1987 Mar;61(3):693–700. doi: 10.1128/jvi.61.3.693-700.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. LoSardo J. E., Boral A. L., Lenz J. Relative importance of elements within the SL3-3 virus enhancer for T-cell specificity. J Virol. 1990 Apr;64(4):1756–1763. doi: 10.1128/jvi.64.4.1756-1763.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Lockyer J. M., McCracken J. B., Jr Identification of a tissue-specific regulatory element within the human muscle glycogen phosphorylase gene. J Biol Chem. 1991 Oct 25;266(30):20262–20269. [PubMed] [Google Scholar]
  22. Lovmand S., Kjeldgaard N. O., Jørgensen P., Pedersen F. S. Enhancer functions in U3 of Akv virus: a role for cooperativity of a tandem repeat unit and its flanking DNA sequences. J Virol. 1990 Jul;64(7):3185–3191. doi: 10.1128/jvi.64.7.3185-3191.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Lozzio B. B., Lozzio C. B., Bamberger E. G., Feliu A. S. A multipotential leukemia cell line (K-562) of human origin. Proc Soc Exp Biol Med. 1981 Apr;166(4):546–550. doi: 10.3181/00379727-166-41106. [DOI] [PubMed] [Google Scholar]
  24. Matsumoto Y., Momoi Y., Watari T., Goitsuka R., Tsujimoto H., Hasegawa A. Detection of enhancer repeats in the long terminal repeats of feline leukemia viruses from cats with spontaneous neoplastic and nonneoplastic diseases. Virology. 1992 Aug;189(2):745–749. doi: 10.1016/0042-6822(92)90598-j. [DOI] [PubMed] [Google Scholar]
  25. Neil J. C., Fulton R., Rigby M., Stewart M. Feline leukaemia virus: generation of pathogenic and oncogenic variants. Curr Top Microbiol Immunol. 1991;171:67–93. doi: 10.1007/978-3-642-76524-7_4. [DOI] [PubMed] [Google Scholar]
  26. Overbaugh J., Donahue P. R., Quackenbush S. L., Hoover E. A., Mullins J. I. Molecular cloning of a feline leukemia virus that induces fatal immunodeficiency disease in cats. Science. 1988 Feb 19;239(4842):906–910. doi: 10.1126/science.2893454. [DOI] [PubMed] [Google Scholar]
  27. Rezanka L. J., Rojko J. L., Neil J. C. Feline leukemia virus: pathogenesis of neoplastic disease. Cancer Invest. 1992;10(5):371–389. doi: 10.3109/07357909209024796. [DOI] [PubMed] [Google Scholar]
  28. Riedel N., Hoover E. A., Gasper P. W., Nicolson M. O., Mullins J. I. Molecular analysis and pathogenesis of the feline aplastic anemia retrovirus, feline leukemia virus C-Sarma. J Virol. 1986 Oct;60(1):242–250. doi: 10.1128/jvi.60.1.242-250.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Rohn J. L., Overbaugh J. In vivo selection of long terminal repeat alterations in feline leukemia virus-induced thymic lymphomas. Virology. 1995 Jan 10;206(1):661–665. doi: 10.1016/s0042-6822(95)80085-9. [DOI] [PubMed] [Google Scholar]
  30. Sarma P. S., Log T. Subgroup classification of feline leukemia and sarcoma viruses by viral interference and neutralization tests. Virology. 1973 Jul;54(1):160–169. doi: 10.1016/0042-6822(73)90125-6. [DOI] [PubMed] [Google Scholar]
  31. Short M. K., Okenquist S. A., Lenz J. Correlation of leukemogenic potential of murine retroviruses with transcriptional tissue preference of the viral long terminal repeats. J Virol. 1987 Apr;61(4):1067–1072. doi: 10.1128/jvi.61.4.1067-1072.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Speck N. A., Renjifo B., Hopkins N. Point mutations in the Moloney murine leukemia virus enhancer identify a lymphoid-specific viral core motif and 1,3-phorbol myristate acetate-inducible element. J Virol. 1990 Feb;64(2):543–550. doi: 10.1128/jvi.64.2.543-550.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Stewart M. A., Warnock M., Wheeler A., Wilkie N., Mullins J. I., Onions D. E., Neil J. C. Nucleotide sequences of a feline leukemia virus subgroup A envelope gene and long terminal repeat and evidence for the recombinational origin of subgroup B viruses. J Virol. 1986 Jun;58(3):825–834. doi: 10.1128/jvi.58.3.825-834.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Tzavaras T., Stewart M., McDougall A., Fulton R., Testa N., Onions D. E., Neil J. C. Molecular cloning and characterization of a defective recombinant feline leukaemia virus associated with myeloid leukaemia. J Gen Virol. 1990 Feb;71(Pt 2):343–354. doi: 10.1099/0022-1317-71-2-343. [DOI] [PubMed] [Google Scholar]
  35. Yoshimura F. K., Davison B., Chaffin K. Murine leukemia virus long terminal repeat sequences can enhance gene activity in a cell-type-specific manner. Mol Cell Biol. 1985 Oct;5(10):2832–2835. doi: 10.1128/mcb.5.10.2832. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Yoshimura F. K., Diem K., Chen H., Tupper J. A protein-binding site with dyad symmetry in the long terminal repeat of the MCF13 murine leukemia virus that contributes to transcriptional activity in T lymphocytes. J Virol. 1993 Apr;67(4):2298–2304. doi: 10.1128/jvi.67.4.2298-2304.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Yoshimura F. K., Tupper J., Diem K. Differential DNA binding of nuclear proteins to a long terminal repeat region of the MCF13 and Akv murine leukemia viruses. J Virol. 1989 Nov;63(11):4945–4948. doi: 10.1128/jvi.63.11.4945-4948.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES